INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ( "Simulations Plus" or the "Company" ) SLP. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investors are Notified of the Ongoing Securities Fraud Investigation -- Contact BFA Law if You Suffered Losses ( NASDAQ:SLP ) - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. SLP for potential violations of the federal securities laws.
SLP SECURITIES: Simulations Plus, Inc. Shareholders that Lost Money may have been Affected by Fraud -- Contact BFA Law ( NASDAQ:SLP ) - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. SLP for potential violations of the federal securities laws.
SLP LOSS ALERT: Simulations Plus, Inc. Investors with Losses are Reminded of the Ongoing Securities Fraud Investigation - Contact BFA Law ( NASDAQ:SLP ) - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 17, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. SLP for potential violations of the federal securities laws.
Simulations Plus ( SLP ) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - Simulations Plus ( NASDAQ:SLP )
SAN FRANCISCO, Aug. 15, 2025 ( GLOBE NEWSWIRE ) -- Investors in Simulations Plus, Inc. ( NASDAQ:SLP ) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 2025 $67.3 million net loss that included a $77.2 million impairment charge and the company's ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ( "Simulations Plus" or the "Company" ) SLP. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Simulations Plus ( SLP ) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal - Hagens Berman - Simulations Plus ( NASDAQ:SLP )
SAN FRANCISCO, Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Investors in Simulations Plus, Inc. ( NASDAQ:SLP ) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 2025 $67.3 million net loss that included a $77.2 million impairment charge and the company's ...
SLP BREAKING INVESTIGATION: BFA Law Announces an Investigation into Simulations Plus, Inc. after Stock Plummets over 25% on Impairment Charges - Contact BFA Law if You Lost Money - Simulations Plus ( NASDAQ:SLP )
NEW YORK, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. SLP for potential violations of the federal securities laws.
INVESTOR ALERT: Investigation of Simulations Plus, Inc. ( SLP ) Announced by Holzer & Holzer, LLC - Simulations Plus ( NASDAQ:SLP )
ATLANTA, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether Simulations Plus, Inc. ( "Simulations Plus" or the "Company" ) SLP complied with federal securities laws. On July 14, 2025, Simulations Plus reported financial results for its third quarter fiscal 2025.
Simulations Plus ( SLP ) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - Simulations Plus ( NASDAQ:SLP )
SAN FRANCISCO, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Investors in Simulations Plus, Inc. ( NASDAQ:SLP ) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 2025 $67.3 million net loss that included a $77.2 million impairment charge and the company's ...
Telefonica's Q2 Earnings Match, Top Line Misses Estimates & Slides Y/Y
TEF's Q2 net income plunges 67% but organic revenue rises 1.5% as it reshapes its portfolio and reaffirms 2025 guidance.
ITRI Q2 Earnings Beat, Sales Lag, Stock Sinks 10% on Mixed Outlook
Itron posts record Q2 2025 earnings and raises EPS outlook, but shares fall 10% on trimmed revenue forecast and mixed segment trends.
Blackbaud's Q2 Earnings Beat Estimates & Rise Y/Y, Stock Up
BLKB tops Q2 earnings estimates, raises full-year guidance across the board, citing strong execution and resilient growth.
Fortive's Q2 Earnings Miss Estimates, Revenues Beat, Stock Down
FTV misses Q2 EPS estimates but beats on revenue. It completes the Ralliant spin-off and reaffirms full-year earnings guidance.
Sensata's Q2 Earnings & Revenues Surpass Estimates, Decrease Y/Y
ST's Q2 revenues fall 8.9% but top forecasts, as growth in Sensing Solutions helps soften weakness in Performance Sensing.
Cadence Q2 Earnings & Revenues Surpass Estimates, Rise Y/Y, Stock Up
CDNS stock jumps as second-quarter EPS and revenues beat estimates, fueled by AI-driven demand and upgraded FY25 guidance.
Flex Q1 Earnings & Revenues Beat Estimates, Up Y/Y, Stock Down
FLEX beats Q1 forecasts and lifts FY26 outlook, but shares fall 7.7% despite robust data center and power gains.
Plexus' Q3 Earnings Surpass Estimates, Revenues Miss Marginally
PLXS' third-quarter earnings of $1.90 per share beat estimates but revenues of $1.018 billion narrowly miss the consensus estimate.
INVESTOR ALERT: Investigation of Simulations Plus, Inc. ( SLP ) Announced by Holzer & Holzer, LLC - Simulations Plus ( NASDAQ:SLP )
ATLANTA, July 23, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether Simulations Plus, Inc. ( "Simulations Plus" or the "Company" ) SLP complied with federal securities laws. On July 14, 2025, Simulations Plus reported financial results for its third quarter fiscal 2025.
America Movil Q2 Earnings Miss, Revenues Up Y/Y on Business Momentum
AMX swings to profit in Q2 2025 with surging service revenues and 1.7M new wireless subscribers but misses EPS estimates.
SAP's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls
SAP posts 37% EPS growth and 24% cloud revenue surge, but shares slip after mixed Q2 results and currency concerns.
Badger Meter's Q2 Earnings Miss Estimates, Revenues Beat, Stock Down
BMI's Q2 sales rise 10% on utility water strength and SmartCover synergies, even as EPS misses expectations.
Simulations Plus Sees Weaker Demand Persist, Outlook Softens - Simulations Plus ( NASDAQ:SLP )
Q3 sales of $20.4 million missed the $20.9M consensus; EPS rose to $0.43 from $0.27 last year. FY25 EPS guidance cut to $0.93-$1.06 from $1.07-$1.20; net loss was $67.3 million on a $77.2 million impairment. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Simulations Plus ...
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views - Kairos Pharma ( AMEX:KAPA ) , BloomZ ( NASDAQ:BLMZ )
U.S. stocks traded mixed midway through trading, with the Nasdaq gaining more than 100 points on Tuesday. The Dow traded down 0.57% to 44,204.33 while the NASDAQ gained 0.71% to 20,786.86. The S&P 500 also rose, gaining, 0.01% to 6,269.15. Information technology shares jumped by 1.6% on Tuesday.
SLP's Q3 Earnings Top, Sales Up Y/Y, Stock Gains Despite Lowered View
Simulation Plus' fiscal Q3 2025 earnings surge 67% on Pro-ficiency gains, but a cut in 2025 outlook shows hurdles in biosimulation and services.
Simulations Plus ( SLP ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Need a quote from one of our analysts? Email [email protected] Plus ( NASDAQ:SLP ) reported mixed operational results for Q3 FY2025, as inorganic revenue gains from acquisitions were offset by organic decline and profitability was burdened by a substantial ...
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Blue Gold ( NASDAQ:BGL ) , FB Financial ( NYSE:FBK )
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Tuesday. Shares of Simulations Plus, Inc SLP fell sharply in pre-market trading after the company reported downbeat third-quarter sales and cut its FY2025 EPS guidance.
This Carrier Global Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Carrier Global ( NYSE:CARR ) , Atlas Energy Solutions ( NYSE:AESI )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Scott Schoenhaus downgraded the rating for Simulations Plus, Inc.
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Ansys ( NASDAQ:ANSS ) , BloomZ ( NASDAQ:BLMZ )
Shares of The Trade Desk, Inc. TTD rose sharply in pre-market trading following the announcement of its inclusion in the S&P 500 index. This development comes after the S&P Dow Jones Indices revealed that The Trade Desk would replace ANSYS Inc. ANSS in the S&P 500, effective from the market open ...
PTC Inc. ( PTC ) Soars 17.7%: Is Further Upside Left in the Stock?
PTC Inc. (PTC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Simulations Plus ( SLP ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt - Simulations Plus ( NASDAQ:SLP )
Simulations Plus cut 2025 revenue forecast to $76 million-$80 million vs. prior $90 million-$93 million and consensus of $90.3 million. Q3 revenue now expected between $19 million-$20 million, well below the $22.78 million analyst estimate.
SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization
Simulations Plus lowers FY25 revenue forecast and restructures operations as biotech headwinds hit services demand.
Rubrik, Inc. ( RBRK ) Reports Q1 Loss, Tops Revenue Estimates
Rubrik, Inc. (RBRK) delivered earnings and revenue surprises of 54.55% and 7.02%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Credo Technology's Q4 Earnings and Sales Beat Estimates, Rise Y/Y
CRDO posts solid Q4 and FY25 earnings, fueled by surging AI demand. It records a 179.7% quarterly revenue jump on booming product sales.
Nebius' Q1 Loss Widens Y/Y, Revenues Rise on Strong Core AI Growth
NBIS reports first-quarter results wherein revenues grow year over year, driven by solid growth in its core AI business.
SLP Advances Predictive Toxicology With DILIsym 11: Shares to Benefit?
Simulations Plus unveils DILIsym 11, an upgraded version of its flagship QST platform to advance predictive toxicology and pediatric liver assessment safety.
Dolby Q2 Earnings Beat Estimates, Revenue Miss, Stock Down
DLB's Q2 earnings rise year over year and beat estimates. Revenues grow but lag expectations.
Blackbaud's Q1 Earnings Beat Estimates & Rise Y/Y, Revenues Down
BLKB's first-quarter earnings and revenues surpass estimates. It reiterates its guidance for full-year 2025.
ANSYS Q1 Earnings & Revenues Miss Estimates, Increase Y/Y, Stock Falls
ANSS first-quarter earnings and revenues lag estimates. The top line rises year over year, driven by strong maintenance, service and subscription lease growth.
Cadence's Q1 Earnings & Revenues Surpass Estimates, Surge Y/Y
CDNS reports better-than-expected first-quarter results on solid demand trends and upgrades revenue and EPS guidance for 2025.
SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Demand, Stock Up
SAP's first-quarter 2025 earnings and revenues increase year over year. It remains confident in its growth trajectory and has reiterated its outlook.
Iridium's Q1 Earnings & Revenues Top, Increase Y/Y, Shares Tumble
IRDM's Q1 performance is led by higher service revenues and subscriber strength. The stock falls 6.9% due to potential global trade volatility and rising costs.
Badger Meter Q1 Earnings Beat on Solid Revenue Growth, Shares Soar 10%
BMI's Q1 2025 performance is powered by the continued adoption of its digital water solutions and synergy from the SmartCover acquisition.
Gold Gains Over 2%; US Consumer Sentiment Dips In April - Mixed Martial Arts Group ( AMEX:MMA ) , Innovative Eyewear ( NASDAQ:LUCY )
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 300 points on Friday. The Dow traded up 0.78% to 39,903.35 while the NASDAQ gained 1.14% to 16,573.81. The S&P 500 also rose, gaining, 0.92% to 5,316.66. Information technology shares surged by 1.2% on Friday.
Recursion Pharmaceuticals Shares Are Up Today: what's Going On? - Recursion Pharmaceuticals ( NASDAQ:RXRX )
he FDA is officially moving away from mandatory animal testing in drug development, opting instead for AI-driven models. Recursion Pharmaceuticals and other AI-focused biotech companies saw sharp share price increases-between 15% and 25%.
What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday? - Simulations Plus ( NASDAQ:SLP ) , Certara ( NASDAQ:CERT ) , Charles River ( NYSE:CRL )
FDA to begin accepting AI-based models, lab-grown organoids instead of traditional animal tests for monoclonal antibody evaluations. A pilot program launching this year to assess non-animal-based testing for select therapies, with broader policy changes expected to follow.
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Amarin Corp ( NASDAQ:AMRN ) , Absci ( NASDAQ:ABSI )
U.S. stocks were lower, with the Dow Jones index dipping over 250 points on Friday. Shares of Fastenal Company FAST rose sharply during Thursday's session following better-than-expected first-quarter sales.
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - argenx ( NASDAQ:ARGX ) , AlTi Global ( NASDAQ:ALTI )
Shares of argenx SE ARGX rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. argenx shares jumped 5.1% to $573.88 in ...
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Absci ( NASDAQ:ABSI ) , Certara ( NASDAQ:CERT )
The FDA will phase out animal testing in favor of AI-based computational models of toxicity and cell lines and organoid toxicity testing. "This initiative marks a paradigm shift in drug evaluation," the FDA says.
